Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 7
1993 6
1994 17
1995 14
1996 22
1997 22
1998 28
1999 34
2000 28
2001 27
2002 22
2003 22
2004 30
2005 32
2006 29
2007 36
2008 27
2009 43
2010 52
2011 32
2012 37
2013 35
2014 33
2015 44
2016 57
2017 51
2018 25
2019 31
2020 45
2021 46
2022 32
2023 20
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

925 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Rocuronium Bromide Intravenous Solution Maruishi is more suitable than ESLAX Intravenous during rapid-sequence induction of anesthesia.
Tachikawa M, Asai T, Okuda Y. Tachikawa M, et al. J Anesth. 2019 Oct;33(5):600-603. doi: 10.1007/s00540-019-02673-x. Epub 2019 Aug 21. J Anesth. 2019. PMID: 31435739 Clinical Trial.
PURPOSE: Rocuronium Bromide Intravenous Solution (Maruishi Pharmaceutical Co., Ltd, Osaka, Japan) is a newly developed generic drug and we have noticed that compared with conventional rocuronium formulations [e.g. ...The degree of movement was also significan …
PURPOSE: Rocuronium Bromide Intravenous Solution (Maruishi Pharmaceutical Co., Ltd, Osaka, Japan) is a newly developed generic …
Effect of Rocuronium vs Succinylcholine on Endotracheal Intubation Success Rate Among Patients Undergoing Out-of-Hospital Rapid Sequence Intubation: A Randomized Clinical Trial.
Guihard B, Chollet-Xémard C, Lakhnati P, Vivien B, Broche C, Savary D, Ricard-Hibon A, Marianne Dit Cassou PJ, Adnet F, Wiel E, Deutsch J, Tissier C, Loeb T, Bounes V, Rousseau E, Jabre P, Huiart L, Ferdynus C, Combes X. Guihard B, et al. JAMA. 2019 Dec 17;322(23):2303-2312. doi: 10.1001/jama.2019.18254. JAMA. 2019. PMID: 31846014 Free PMC article. Clinical Trial.
IMPORTANCE: Rocuronium and succinylcholine are often used for rapid sequence intubation, although the comparative efficacy of these paralytic agents for achieving successful intubation in an emergency setting has not been evaluated in clinical trials. Succinylcholine use h …
IMPORTANCE: Rocuronium and succinylcholine are often used for rapid sequence intubation, although the comparative efficacy of these p …
Pharmacological and non-pharmacological interventions for reducing rocuronium bromide induced pain on injection in children and adults.
Prabhakar H, Singh GP, Ali Z, Kalaivani M, Smith MA. Prabhakar H, et al. Cochrane Database Syst Rev. 2016 Feb 12;2(2):CD009346. doi: 10.1002/14651858.CD009346.pub2. Cochrane Database Syst Rev. 2016. PMID: 26871982 Free PMC article. Review.
BACKGROUND: Rocuronium bromide is a routinely used muscle relaxant in anaesthetic practice. ...Various strategies, both pharmacological and non-pharmacological, have been studied to reduce the incidence and severity of pain on rocuronium bromide inject …
BACKGROUND: Rocuronium bromide is a routinely used muscle relaxant in anaesthetic practice. ...Various strategies, both pharma …
Fentanyl versus placebo with ketamine and rocuronium for patients undergoing rapid sequence intubation in the emergency department: The FAKT study-A randomized clinical trial.
Ferguson I, Buttfield A, Burns B, Reid C, Shepherd S, Milligan J, Harris IA, Aneman A; Australasian College for Emergency Medicine Clinical Trials Network. Ferguson I, et al. Acad Emerg Med. 2022 Jun;29(6):719-728. doi: 10.1111/acem.14446. Epub 2022 Mar 15. Acad Emerg Med. 2022. PMID: 35064992 Free PMC article. Clinical Trial.
A total of 290 participants were randomized to receive either fentanyl or 0.9% saline (placebo) in combination with ketamine and rocuronium, according to a weight-based dosing schedule. The primary outcome was the proportion of patients in each group with at least one SBP …
A total of 290 participants were randomized to receive either fentanyl or 0.9% saline (placebo) in combination with ketamine and rocuroni …
Comparation Among Opioid-Based, Low Opioid and Opioid Free Anesthesia in Colorectal Oncologic Surgery.
Toleska M, Dimitrovski A, Dimitrovska NT. Toleska M, et al. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2023 Mar 29;44(1):117-126. doi: 10.2478/prilozi-2023-0013. Print 2023 Mar 1. Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2023. PMID: 36987755 Free article. Clinical Trial.
The first group of patients, or Opioid-based anesthesia group (OBAG), received the following for induction to anesthesia: lidocaine at 1 mg/kg, fentanyl 100 at gr, propofol at 2mg/kg and rocuronium bromide at 0.6 mg/kg. They intermittently received 50-100 gr fentany …
The first group of patients, or Opioid-based anesthesia group (OBAG), received the following for induction to anesthesia: lidocaine at 1 mg/ …
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.
Hristovska AM, Duch P, Allingstrup M, Afshari A. Hristovska AM, et al. Cochrane Database Syst Rev. 2017 Aug 14;8(8):CD012763. doi: 10.1002/14651858.CD012763. Cochrane Database Syst Rev. 2017. PMID: 28806470 Free PMC article. Review.
Twelve trials were eligible for meta-analysis of primary outcomes (n = 949), 28 trials were eligible for meta-analysis of secondary outcomes (n = 2298), and 10 trials (n = 1647) were ineligible for meta-analysis.We compared sugammadex 2 mg/kg and neostigmine 0.05 mg/kg for revers …
Twelve trials were eligible for meta-analysis of primary outcomes (n = 949), 28 trials were eligible for meta-analysis of secondary outcomes …
Optimal dose of rocuronium bromide undergoing adenotonsillectomy under 5% sevoflurane with fentanyl.
Huh H, Park JJ, Kim JY, Kim TH, Yoon SZ, Shin HW, Lee HW, Lim HJ, Cho JE. Huh H, et al. Int J Pediatr Otorhinolaryngol. 2017 Oct;101:70-74. doi: 10.1016/j.ijporl.2017.07.030. Epub 2017 Jul 25. Int J Pediatr Otorhinolaryngol. 2017. PMID: 28964314 Clinical Trial.

RESULTS: Rocuronium groups (96% and 100%, respectively; P < 0.01) showed statistically superior clinically acceptable intubating conditions than the saline group (72%). The 0.3 mg/kg rocuronium (80%) treatment clearly resulted in excellent intubating conditions c

…

RESULTS: Rocuronium groups (96% and 100%, respectively; P < 0.01) showed statistically superior clinically acceptable intubating c

…
Protective Effects of Rocuronium Bromide on Ischemia-Reperfusion Injury in Skeletal Muscle Induced by Tourniquet in Patients Undergoing Elective Unilateral Total Knee Arthroplasty: A Prospective, Double Blind, Randomized, Controlled Study.
Chen H, Wei JQ, Wang YW, Zhou KP, He Y, Liu H, Zhang YY. Chen H, et al. Drug Des Devel Ther. 2020 Aug 18;14:3373-3384. doi: 10.2147/DDDT.S252546. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32884241 Free PMC article. Clinical Trial.
The concentration of MDA in the rocuronium 1.2 mg/kg group was lower at 30 min after reperfusion (P < 0.05). ...CONCLUSION: Rocuronium can protect skeletal muscle from ischemia-reperfusion injury induced by tourniquet. ...

The concentration of MDA in the rocuronium 1.2 mg/kg group was lower at 30 min after reperfusion (P < 0.05). ...CONCLUSION: Roc

…
[Influence of gender on the potency and course of action of rocuronium bromide].
Steinberg D. Steinberg D. Rev Esp Anestesiol Reanim. 2009 Dec;56(10):604-11. doi: 10.1016/s0034-9356(09)70476-1. Rev Esp Anestesiol Reanim. 2009. PMID: 20151522 Review. Spanish.
OBJECTIVE: The correlation between gender and the potency of certain neuromuscular blockers, including rocuronium, has been investigated. However, the methods used have been inconsistent. ...CONCLUSIONS: These results suggest that there is no significant effect of gender o …
OBJECTIVE: The correlation between gender and the potency of certain neuromuscular blockers, including rocuronium, has been investiga …
Rocuronium bromide: time-course of action in underweight, normal weight, overweight and obese patients.
Pühringer FK, Khuenl-Brady KS, Mitterschiffthaler G. Pühringer FK, et al. Eur J Anaesthesiol Suppl. 1995 Sep;11:107-10. Eur J Anaesthesiol Suppl. 1995. PMID: 8556996 Clinical Trial.
The duration of action and recovery of 0.6 mg kg-1 rocuronium in underweight, normal weight, overweight and obese patients were investigated. Forty-eight patients were divided into four groups, according to their body mass index, and were given 0.6 mg kg-1 rocuronium …
The duration of action and recovery of 0.6 mg kg-1 rocuronium in underweight, normal weight, overweight and obese patients were inves …
925 results